LTGO LTGO
Company Profile ↓Company Overview
LTGO (LTGO) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Growth & Price Performance
Stock Price Performance
| 1 Year: | +26.25% |
| 6 Months: | - |
| 3 Months: | - |
| 1 Month: | - |
- RSI (14)66.45 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Jun 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Operating Income | - | -25.75M | - | -25.81M |
| Net Income | -20.95M | -25.84M | -22.96M | -25.80M |
| Diluted EPS | - | -36.52 | - | -27.59 |
| R&D Expense | - | 22.92M | - | 21.23M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Total Assets | 22.86M | 75.52M |
| Current Assets | 21.16M | 73.83M |
| Cash & Equivalents | 17.92M | 69.44M |
| Inventory | - | - |
| Receivables | - | - |
| Total Liabilities | 152.46M | 307.19M |
| Current Liabilities | 14.44M | 18.45M |
| Long Term Debt | - | - |
| Total Debt | 851.00K | 690.00K |
| Total Equity | -129.60M | -231.67M |
| Shares Outstanding | - | - |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Operating Cash Flow | -50.95M | -97.56M |
| Investing Cash Flow | -72.00K | -136.00K |
| Financing Cash Flow | 607.00K | 149.50M |
| Capital Expenditure | -72.00K | -136.00K |
| Free Cash Flow | -51.03M | -97.69M |
| Net Change in Cash | -50.42M | 51.80M |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for LTGO
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE9wSWdmd2sta3BNUGlIamlaVDdOM1ZxbWdYZzFzcWdXdVZnUklMZUI5MjUzMlo2dkZKRnFEOVIzRmNMS3llX3B6blJWNHh6dFI0?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <fon…
Latigo Biotherapeutics (NASDAQ:LTGO) Downgraded by Wall Street Zen to Sell - marketbeat.com
<a href="https://news.google.com/rss/articles/CBMizwFBVV95cUxPU3hoVnRTZC1pMDN4ODVBZ2NzcUctUmNFeFdGYm0zaGN1NGFfZFBiNUlvUmxTT0tfN0tiSHNYYldwSGd2R0J0ei1tXzdRSm8xaHlrX0JGY2d6QkhVVzF6YTNKdDJXNzFZTzVtdWZOYjJ6cmlvVG04djdnYmtOY0hmME1weXhEdDZxVkZ3Zz…
Latigo Biotherapeutics, Inc.: Revenue and Earnings Analysts Forecasts Revisions | LTGO | US5179541033 - marketscreener.com
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxOYWJ2ZmlYRE4yME1oTDhaWlhmTmZVcnFxYWdwSnJRejY4eUhjdU5hX195ZWVPUlRnT1BqWkRMWGpEdUpLNXYzdXpLM2VyMkJsOHJKMWlTQzA4eUVFb2pMM1JkVWRYXzg4MGx3OU5abEUxaDk0Y1NQb21iakhYYUJ2UnZ6blZ3M18xeHhlSj…
Latigo Biotherapeutics (LTGO) draws 4.45M-share stake from Deep Track - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxQN3RITHE5dmloRVNiYjhKMGFHSTdCaFJGT01ERkd0UlBYcXNIOXFwSWFib0xnRHF3NEVRblI4amM3OVd2WlJNbFZHV2ZwcHpISC1CalBLR2ZCYlVMLUZ5ZWlrXzhranVMNUdwUjRNN1ZVcUVadGxJOXloLTRHcnFpaGZFUlRkM2hjSVA0SW…
Latigo Biotherapeutics (NASDAQ:LTGO) Stock Rating Upgraded by Guggenheim - marketbeat.com
<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxOdlVESVc2YkZMQ1lTX2szelI5T0hhX1QzODlPSExUc09qMW5DTGo3NVhmd29NOW9MTGVuLW1JbWJjT1dsYnFTMkIzVjlRaHRYRUFwOUMtMktQS2t0Q2tDbXJQcUgtQzhpRGZPSW5lSEs4UUlUNGxnRlBoUnpoanpET3NkOFhJZzl4VmZiUG…
Latigo Biotherapeutics (LTGO) IPO & Stock Profile - renaissancecapital.com
<a href="https://news.google.com/rss/articles/CBMif0FVX3lxTFBfdDVaWDJPTWdWY3BNS1VScTQ3RE5TRy1QRW5rSGtHdzhBYnFZZWxBdGhZUnRSNEtVdDhVYzVMS1hvM1B4a2w0VzlCM3NwLVZzUm1sT3pJVnpJT1drbUJHbGJZb2RZaUxJWmFEemVOSm1MUWhJLU9YODM3U2Q5Yk0?oc=5" target="_bla…
LTGO — Frequently Asked Questions
What is the current share price of LTGO?
As of 2026-09-07 16:24 PDT, LTGO trades at $23.04 on NASDAQ/NYSE. Its 52-week range is $18.25 to $25.00.
Is LTGO a good stock to buy?
This page provides a data-driven analysis of LTGO, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.